在前上颌单一位点侧向骨增量中比较dPTFE膜与胶原膜的多中心随机对照试验:1年结果
多中心随机对照试验纳入前上颌单一位点4类骨缺损患者36例,比较dPTFE膜与胶原膜在侧向骨增量中的效果。9个月时两组牙槽嵴宽度估计边际均值差异无统计学显著(嵴下3mm处差异0.65mm,95%CI -0.82至2.12,p=0.381)。dPTFE膜组感染6/18例,胶原膜组0/18例(p=0.019)。结论认为两种膜均有效,但dPTFE膜更易感染,增加额外治疗需求。
要点
- 9个月时两组牙槽嵴宽度差异无统计学显著,嵴下3mm处估计边际均值差异0.65mm(95%CI -0.82至2.12,p=0.381)。
- dPTFE膜组感染6/18例,胶原膜组0/18例(p=0.019),感染对9个月时牙槽嵴宽度有负面影响。
- 所有患者均完成1年随访,种植体可按修复驱动位置植入并顺利整合,边缘骨丧失极小。
核心结论
- dPTFE膜与胶原膜在侧向骨增量中均有效,但dPTFE膜比胶原膜更易发生感染,从而增加额外治疗需求。
研究设计与样本
- 多中心随机对照试验,在前上颌单一位点(15-25)4类骨缺损患者中比较dPTFE膜与胶原膜用于侧向骨增量的效果。
- 共招募36例患者并随机分组:dPTFE膜组8例女性、10例男性,平均年龄39岁;胶原膜组14例女性、4例男性,平均年龄51岁。
- 所有患者均完成至1年随访;骨增量术后9个月行二次入路并植入种植体。
- 牙槽尺寸通过术前、术后即刻及9个月时叠加的锥形束CT图像评估;种植体结局在骨增量术后1年记录。
- 试验注册号:ClinicalTrials.gov NCT05426616。
主要发现
- 9个月时两组估计边际平均牙槽嵴宽度无显著差异(嵴下3mm处估计边际均值差异0.65mm;95%CI -0.82至2.12;p=0.381)。
- dPTFE膜组感染6/18例,胶原膜组感染0/18例(p=0.019)。
- 感染在每个中心均有发生,尽管每位患者均采取抗感染措施、其中两名患者接受额外骨增量,感染仍对9个月时牙槽嵴宽度产生负面影响。
- 种植体可按修复驱动位置植入,顺利整合,边缘骨丧失极小。
关键数值与推荐
- 9个月时嵴下3mm处牙槽嵴宽度估计边际均值差异0.65mm(95%CI -0.82至2.12;p=0.381),未达统计学显著。
- 感染发生率:dPTFE膜组6/18例 vs 胶原膜组0/18例(p=0.019)。
临床怎么用
- 原文结论认为dPTFE膜与胶原膜在侧向骨增量中均有效,但dPTFE膜更易感染并增加额外治疗需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To compare a dense polytetrafluoroethylene (dPTFE) membrane with a collagen membrane in guided bone regeneration for lateral bone augmentation at single sites in the anterior maxilla in terms of alveolar width, height, complications, need for additional therapy and implant outcomes. MATERIALS AND METHODS: Patients with a class 4 defect at a single site in the anterior maxilla (15-25) were recruited at five centres. Following flap elevation and conditioning of the recipient site, they were randomly allocated to the dPTFE membrane group or the collagen membrane group. Nine months following bone augmentation, re-entry was performed and implants were placed. Alveolar dimensions were assessed on superimposed cone-beam computed tomography images taken prior to surgery, immediately post operation and at 9 months. Implant outcomes were registered 1 year after bone augmentation. RESULTS: Thirty-six patients were randomised (dPTFE membrane group: 8 females, 10 males, mean age 39; collagen membrane group: 14 females, 4 males, mean age 51) and all complied until the 1-year follow-up. At 9 months, the estimated marginal mean alveolar width was not significantly different between the groups (estimated marginal mean difference at 3 mm below the crest: 0.65 mm; 95% CI: -0.82 to 2.12; p = 0.381). Infection occurred in 6/18 patients treated with a dPTFE membrane and in 0/18 patients treated with a collagen membrane (p = 0.019). Infection occurred in every centre and had a negative impact on the alveolar width at 9 months, despite taking anti-infective measures in every patient and additional bone augmentation in two patients. Implants could be installed in a prosthetically driven position, integrated uneventfully and yielded minimal marginal bone loss. CONCLUSION: dPTFE membrane and collagen membrane are both effective in lateral bone augmentation. However, dPTFE membrane is more prone to infection than collagen membrane, thereby increasing the need for additional therapy. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05426616.
引用
- Hindryckx M, De Bruyckere T, De Buyser S, et al. A Multi-Centre Randomised Controlled Trial Comparing dPTFE Membrane to Collagen Membrane in Lateral Bone Augmentation at Single Sites in the Anterior Maxilla: 1-Year Results. J Clin Periodontol. 2025. PMID: 40298001. doi:10.1111/jcpe.14174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。